semaglutide alzheimer's study Efficacy and safety of oral 14 mg (flexible dose) in early-stage symptomatic disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials Semaglutide's Alzheimer's Trial Failure: Rethinking

Blue Cross Blue Shield Association About BCBS Multiple BCBS affiliates dropped or restricted weight-loss GLP-1 coverage in 20242025, including Independence Blue Cross (1/1/2025), BCBS of Michigan (1/1/2025), and Blue Shield of CA (BMI 40 new-start rule from 1/1/2025)

Many patients add the HIFU Treatment in the weeks following a successful cycle to address skin tone and firmness as fat reduces

These findings may have consequences for cardiovascular safety because they point to a change in the lipoprotein profile of T2DM patients taking tirzepatide toward a less atherogenic one and a net improvement in insulin sensitivity [38]

Compared to many other peptides, it supports balanced results rather than short term spikes

Glucagon receptor agonism in metabolic disease: revisiting an old target

Myth #1: Med spas only benefit your looksnot your well-being. Its easy to dismiss med spas as superficial, but that perspective ignores the many unique reasons people seek this type of care